CYAD - Celyad Oncology SA (CYAD) CEO Filippo Petti on Q4 2021 Results - Earnings Call Transcript

Celyad Oncology SA (CYAD) Q4 2021 Earnings Conference Call March 25, 2022 08:00 ET CompanyParticipants Daniel Ferry - LifeSci Advisors Filippo Petti - Chief Executive Officer Charles Morris - Chief Medical Officer David Gilham - Chief Scientific Officer Conference Call Participants Raju Prasad - William Blair Ed White - H.C. Wainright Nick Abbott - Wells Fargo Presentation Operator Welcome to the Celyad Oncology Second Half 2021 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After management’s prepared remarks, there will be an opportunity to ask questions. [Operator Instructions] Please note, this event is being recorded. I'd now like to turn the conference over to Dan Ferry, Managing Director with LifeSci Advisors. Please go ahead, sir. Daniel Ferry Thank you all for joining us today. Before we begin, I would like to remind everyone that today's event may contain forward-looking statements within the meaning of applicable

For further details see:

Celyad Oncology SA (CYAD) CEO Filippo Petti on Q4 2021 Results - Earnings Call Transcript